Location History:
- Abington, GB (2010 - 2017)
- Great Abington, GB (2019 - 2022)
Company Filing History:
6 out of 263 
6 out of 24 
5 out of 68 
Years Active: 2010-2022
Title: Innovations of Harry Finch in Cancer Research
Introduction
Harry Finch is a notable inventor based in Abington, GB, recognized for his contributions to the field of cancer research. He holds a total of six patents, showcasing his innovative approach to developing treatments for various diseases, particularly cancers.
Latest Patents
Among his latest patents is a significant invention involving isoxazole compounds as inhibitors of heat shock proteins. These compounds are designed to inhibit HSP90 activity, which is crucial in the treatment of cancers. The isoxazoles are characterized by specific chemical formulas that include various substituents, making them versatile in their application for cancer therapies.
Career Highlights
Throughout his career, Harry Finch has made substantial contributions to cancer research. He has worked with prominent organizations such as Cancer Research Technology Limited and the Institute of Cancer Research, where he has furthered his research and development efforts.
Collaborations
Harry Finch has collaborated with notable colleagues in the field, including Martin James Drysdale and Brian William Dymock. These collaborations have enhanced his research capabilities and contributed to the advancement of cancer treatment methodologies.
Conclusion
Harry Finch's innovative work in developing isoxazole compounds and his collaborations with esteemed colleagues highlight his significant impact on cancer research. His contributions continue to pave the way for advancements in medical treatments.